XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Impact of ASC 842 adoption
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Impact of ASC 842 adoption
Beginning balance (in shares) at Dec. 31, 2020 0          
Beginning balance at Dec. 31, 2020 $ 0          
Ending balance (in shares) at Mar. 31, 2021 0          
Ending balance at Mar. 31, 2021 $ 0          
Beginning balance (in shares) at Dec. 31, 2020     31,432,477      
Beginning balance at Dec. 31, 2020 (949)   $ 3 $ 57,097 $ (58,049)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised (in shares)     257,444      
Stock options exercised 84     84    
Stock-based compensation expense 80     80    
Net (loss) income 8,090       8,090  
Ending balance (in shares) at Mar. 31, 2021     31,689,921      
Ending balance at Mar. 31, 2021 $ 7,305   $ 3 57,261 (49,959)  
Beginning balance (in shares) at Dec. 31, 2020 0          
Beginning balance at Dec. 31, 2020 $ 0          
Ending balance (in shares) at Dec. 31, 2021 0          
Ending balance at Dec. 31, 2021 $ 0          
Beginning balance (in shares) at Dec. 31, 2020     31,432,477      
Beginning balance at Dec. 31, 2020 $ (949)   $ 3 57,097 (58,049)  
Ending balance (in shares) at Dec. 31, 2021 97,574,171   97,574,171      
Ending balance at Dec. 31, 2021 $ 40,799 $ (1,962) $ 10 77,632 (36,843) $ (1,962)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Accounting standards update extensible enumeration Accounting Standards Update 2016-02 [Member]          
Ending balance (in shares) at Mar. 31, 2022 0          
Ending balance at Mar. 31, 2022 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised (in shares)     275,435      
Stock options exercised 60     60    
Vesting of restricted stock units (in shares)     378,425      
Repurchases of restricted stock for payroll tax withholding (in shares)     (102,019)      
Repurchases of restricted stock for payroll tax withholding (195)     (195)    
Stock-based compensation expense 1,089     1,089    
Net (loss) income $ (5,558)       (5,558)  
Ending balance (in shares) at Mar. 31, 2022 98,126,012   98,126,012      
Ending balance at Mar. 31, 2022 $ 34,233   $ 10 $ 78,586 $ (44,363)